Related Experiment Video
Updated: May 26, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Advances in pediatric asthma in 2011: moving forward
1Division of Pediatric Clinical Pharmacology and Allergy and Immunology, Department of Pediatrics, National Jewish Health, University of Colorado School of Medicine, Denver, Colo 80206, USA. szeflers@njhealth.org
Recent advances in pediatric asthma have significantly reduced disease burden. New strategies focus on personalized medicine, early childhood identification, and guideline revisions for better asthma management and prevention.
Area of Science:
- Pediatric Pulmonology
- Allergy and Immunology
- Public Health
Background:
- Asthma remains a significant health burden in children, necessitating continuous advancements in management and treatment.
- Previous research highlighted the potential of personalized medicine and improved healthcare access to alleviate pediatric asthma.
- The Journal of Allergy and Clinical Immunology has published key findings relevant to pediatric asthma over the last decade.
Purpose of the Study:
- To summarize recent advances in pediatric asthma management and outcomes.
- To identify pathways for further reducing asthma morbidity and mortality in children.
- To discuss the need for revising asthma guidelines based on new evidence.
Main Methods:
- Review of publications in the Journal of Allergy and Clinical Immunology from 2011.
- Analysis of studies focusing on asthma exacerbation reduction, early childhood disease identification, and asthma progression.
- Consideration of nutritional interventions and guideline implementation.
Main Results:
- Significant accomplishments in reducing pediatric asthma morbidity and mortality over the past 10 years.
- Identification of methods to improve asthma management, including reducing exacerbations and understanding early childhood disease.
- Emphasis on the need for updated asthma guidelines and leveraging electronic medical records for innovative management plans.
Conclusions:
- Continued progress in pediatric asthma care is evident, with notable reductions in disease burden.
- Revision of asthma guidelines is warranted to incorporate recent key studies and improve patient outcomes.
- Innovative disease management plans utilizing electronic medical records can enhance asthma control, leading to potential remission and prevention.
Related Concept Videos
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-IV: Nursing Management
First, in...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma III: Clinical Manifestations